These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1925309)

  • 1. Production of a cytotoxin by Helicobacter pylori.
    Leunk RD
    Rev Infect Dis; 1991; 13 Suppl 8():S686-9. PubMed ID: 1925309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis.
    Zhang QB; Nakashabendi IM; Mokhashi MS; Dawodu JB; Gemmell CG; Russell RI
    Gut; 1996 Jun; 38(6):841-5. PubMed ID: 8984021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic isolates of Helicobacter pylori from peptic ulcer diseases decrease K+-dependent ATPase activity in HeLa cells.
    Shanjana A; Archana A
    BMC Gastroenterol; 2003 Nov; 3():31. PubMed ID: 14604441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases.
    Tee W; Lambert JR; Dwyer B
    J Clin Microbiol; 1995 May; 33(5):1203-5. PubMed ID: 7615729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxin and urease activities of Helicobacter pylori isolates from Japanese patients with atrophic gastritis or duodenal ulcer.
    Murakita H; Hirai M; Ito S; Azuma T; Kato T; Kohli Y; Kuriyama M
    J Gastroenterol Hepatol; 1996 Sep; 11(9):819-24. PubMed ID: 8889959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo.
    Cover TL; Cao P; Lind CD; Tham KT; Blaser MJ
    Infect Immun; 1993 Dec; 61(12):5008-12. PubMed ID: 8225576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro cytotoxic effects of vacuolating cytotoxin produced by clinical isolates of Helicobacter pylori.
    Kodama K; Fujioka T; Ito A; Nishizono A; Nasu M
    Kansenshogaku Zasshi; 1998 Oct; 72(10):1027-34. PubMed ID: 9847519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vacuolating cytotoxin in clinical isolates of Helicobacter pylori.
    Kodama K; Fujioka T; Ito A; Kubota T; Murakami K; Nasu M
    J Gastroenterol; 1996 Nov; 31 Suppl 9():9-11. PubMed ID: 8959510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of monoclonal antibodies neutralizing vacuolation of cultured cells by Helicobacter pylori cytotoxin.
    Yamaguchi H; Osaki T; Taguchi H; Kamiya S
    FEMS Microbiol Lett; 1998 Nov; 168(2):277-82. PubMed ID: 9835039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vacuolating cytotoxin production by Helicobacter pylori isolates from peptic ulcer, atrophic gastritis and gastric carcinoma patients.
    Murakita H; Hirai M; Ito S; Azuma T; Kato T; Kohli Y
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S29-31. PubMed ID: 7735931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vacuolating cytotoxin of Helicobacter pylori.
    Cover TL
    Mol Microbiol; 1996 Apr; 20(2):241-6. PubMed ID: 8733223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis.
    Fox JG; Correa P; Taylor NS; Thompson N; Fontham E; Janney F; Sobhan M; Ruiz B; Hunter F
    Am J Gastroenterol; 1992 Nov; 87(11):1554-60. PubMed ID: 1442673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cytotoxin genotypes of Helicobacter pylori in stomach and saliva.
    Wang J; Chi DS; Laffan JJ; Li C; Ferguson DA; Litchfield P; Thomas E
    Dig Dis Sci; 2002 Aug; 47(8):1850-6. PubMed ID: 12184541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of Helicobacter pylori vacuolating cytotoxin in the hepatocytes of patients with isolated hypertransaminasaemia.
    Francavilla A; Ierardi E; Francavilla R; Principi M; Gentile A; Margiotta M; Balzano T; Passaro S; Noviello F; Panella C; Pollice L
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):669-74. PubMed ID: 10730557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori.
    Cover TL; Cao P; Murthy UK; Sipple MS; Blaser MJ
    J Clin Invest; 1992 Sep; 90(3):913-8. PubMed ID: 1522241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between antibody to cytotoxin and Helicobacter pylori infection.
    Gościniak G; Przondo-Mordarska A; Poniewierka E; Iwańczak B; Bilska A
    J Physiol Pharmacol; 1997 Sep; 48(3):415-21. PubMed ID: 9376624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori vacuolating cytotoxin, VacA.
    Hirayama T; Wada A; Yahiro K; Kimura M; Kimura T
    Jpn J Infect Dis; 2002 Feb; 55(1):1-5. PubMed ID: 11971154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.
    Telford JL; Ghiara P; Dell'Orco M; Comanducci M; Burroni D; Bugnoli M; Tecce MF; Censini S; Covacci A; Xiang Z
    J Exp Med; 1994 May; 179(5):1653-58. PubMed ID: 8163943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of infection with cag A and vac A positive Helicobacter pylori strains].
    Sokić-Milutinović A; Todorović V; Milosavljević T
    Srp Arh Celok Lek; 2004; 132(11-12):458-62. PubMed ID: 15938230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients.
    Hirai M; Azuma T; Ito S; Kato T; Kohli Y; Fujiki N
    Int J Cancer; 1994 Jan; 56(1):56-60. PubMed ID: 8262677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.